Tempus AI, Inc. (NASDAQ: TEM) is set to present at the Goldman Sachs 47th Annual Global Healthcare Conference, highlighting its role in advancing precision medicine through artificial intelligence. The company's Founder and CEO, Eric Lefkofsky, will participate in a fireside chat to discuss the firm's strategic direction and technological advancements. This presentation provides investors and industry stakeholders with direct insight into Tempus's operations and market positioning.

Conference Details

The fireside chat featuring Eric Lefkofsky is scheduled for Monday, June 8, at 2:00 p.m. ET. The session will offer a detailed look at how Tempus leverages its extensive library of multimodal data to support AI-enabled precision medicine solutions. These tools assist physicians in delivering personalized patient care while simultaneously facilitating the discovery and development of new therapeutics.

Access and Availability

Investors and interested parties can access the live webcast of the conversation through the official event link. The session aims to demonstrate how Tempus's operating system makes vast datasets accessible and useful for clinical applications. By providing these tools, the company intends to ensure that each patient benefits from the treatments of others who came before them.

About Tempus AI Inc.

Tempus AI Inc. is a technology company focused on the practical application of artificial intelligence in healthcare. The firm utilizes one of the world's largest libraries of multimodal data to provide precision medicine solutions. Its platform supports physicians in personalized care and aids in the development of optimal therapeutics.